BPC-157 is generally well-tolerated, with minimal reported side effects
Third-party tested, individual component purity reported on the lab certificate
Possibly, the consistent endothelium protection during advanced healing processes in different wounds of various tissues, including blood vessels [1,2,1017], associated with the counteraction of the L-NAME-induced disturbances as well as the counteraction of the L-arginine-induced disturbances, obtained with the same BPC 157 dose range [14,15,1826], should likely compete with the prominent endothelium effect of the heparin-impaired endothelial nitric oxide (NO) synthesis [36] as well as warfarin endothelium damage [37]
Testing rather than guessing provides the clearest guidance
A single-peptide protocol has one mechanism of action to optimize